Global and United States Imatinib Drugs Market Insights, Forecast to 2026

Global and United States Imatinib Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Imatinib Drugs Product Introduction
1.2 Market Segments
1.3 Key Imatinib Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Imatinib Drugs Market Size Growth Rate by Type
1.4.2 Capsules
1.4.3 Tablets
1.5 Market by Application
1.5.1 Global Imatinib Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Drug Stores
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Imatinib Drugs Market Size, Estimates and Forecasts
2.1.1 Global Imatinib Drugs Revenue 2015-2026
2.1.2 Global Imatinib Drugs Sales 2015-2026
2.2 Global Imatinib Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Imatinib Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Imatinib Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Imatinib Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Imatinib Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Imatinib Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Imatinib Drugs Revenue Forecast by Region (2021-2026)
3 Global Imatinib Drugs Competitor Landscape by Players
3.1 Global Top Imatinib Drugs Sales by Manufacturers
3.1.1 Global Imatinib Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Imatinib Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Imatinib Drugs Manufacturers by Revenue
3.2.1 Global Imatinib Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Imatinib Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Imatinib Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Imatinib Drugs Revenue in 2019
3.2.5 Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Imatinib Drugs Price by Manufacturers
3.4 Global Imatinib Drugs Manufacturing Base Distribution, Product Types
3.4.1 Imatinib Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Imatinib Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Imatinib Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Imatinib Drugs Market Size by Type (2015-2020)
4.1.1 Global Imatinib Drugs Sales by Type (2015-2020)
4.1.2 Global Imatinib Drugs Revenue by Type (2015-2020)
4.1.3 Imatinib Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Imatinib Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Imatinib Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Imatinib Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Imatinib Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Imatinib Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Imatinib Drugs Market Size by Application (2015-2020)
5.1.1 Global Imatinib Drugs Sales by Application (2015-2020)
5.1.2 Global Imatinib Drugs Revenue by Application (2015-2020)
5.1.3 Imatinib Drugs Price by Application (2015-2020)
5.2 Imatinib Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Imatinib Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Imatinib Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Imatinib Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Imatinib Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Imatinib Drugs Sales YoY Growth 2015-2026
6.1.2 United States Imatinib Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Imatinib Drugs Market Share in Global Market 2015-2026
6.2 United States Imatinib Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Imatinib Drugs Players by Sales (2015-2020)
6.2.2 United States Top Imatinib Drugs Players by Revenue (2015-2020)
6.3 United States Imatinib Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Imatinib Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Imatinib Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Imatinib Drugs Price by Type (2015-2020)
6.4 United States Imatinib Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Imatinib Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Imatinib Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Imatinib Drugs Price Forecast by Type (2021-2026)
6.5 United States Imatinib Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Imatinib Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Imatinib Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Imatinib Drugs Price by Application (2015-2020)
6.6 United States Imatinib Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Imatinib Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Imatinib Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Imatinib Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Imatinib Drugs Market Size YoY Growth 2015-2026
7.2 North America Imatinib Drugs Market Facts & Figures by Country
7.2.1 North America Imatinib Drugs Sales by Country (2015-2020)
7.2.2 North America Imatinib Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Imatinib Drugs Market Size YoY Growth 2015-2026
8.2 Europe Imatinib Drugs Market Facts & Figures by Country
8.2.1 Europe Imatinib Drugs Sales by Country
8.2.2 Europe Imatinib Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Imatinib Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Imatinib Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Imatinib Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Imatinib Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Imatinib Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Imatinib Drugs Market Facts & Figures by Country
10.2.1 Latin America Imatinib Drugs Sales by Country
10.2.2 Latin America Imatinib Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Imatinib Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Imatinib Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Imatinib Drugs Sales by Country
11.2.2 Middle East and Africa Imatinib Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Apotex Inc.
12.1.1 Apotex Inc. Corporation Information
12.1.2 Apotex Inc. Description and Business Overview
12.1.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Apotex Inc. Imatinib Drugs Products Offered
12.1.5 Apotex Inc. Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Imatinib Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Sanofi S.A.
12.3.1 Sanofi S.A. Corporation Information
12.3.2 Sanofi S.A. Description and Business Overview
12.3.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi S.A. Imatinib Drugs Products Offered
12.3.5 Sanofi S.A. Recent Development
12.4 Cipla Inc.
12.4.1 Cipla Inc. Corporation Information
12.4.2 Cipla Inc. Description and Business Overview
12.4.3 Cipla Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cipla Inc. Imatinib Drugs Products Offered
12.4.5 Cipla Inc. Recent Development
12.5 Mylan Pharms Inc.
12.5.1 Mylan Pharms Inc. Corporation Information
12.5.2 Mylan Pharms Inc. Description and Business Overview
12.5.3 Mylan Pharms Inc. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Pharms Inc. Imatinib Drugs Products Offered
12.5.5 Mylan Pharms Inc. Recent Development
12.6 Glenmark Pharmaceuticals Ltd.
12.6.1 Glenmark Pharmaceuticals Ltd. Corporation Information
12.6.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
12.6.3 Glenmark Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Products Offered
12.6.5 Glenmark Pharmaceuticals Ltd. Recent Development
12.7 Sun Pharmaceuticals
12.7.1 Sun Pharmaceuticals Corporation Information
12.7.2 Sun Pharmaceuticals Description and Business Overview
12.7.3 Sun Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sun Pharmaceuticals Imatinib Drugs Products Offered
12.7.5 Sun Pharmaceuticals Recent Development
12.8 Actavis Generics
12.8.1 Actavis Generics Corporation Information
12.8.2 Actavis Generics Description and Business Overview
12.8.3 Actavis Generics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Actavis Generics Imatinib Drugs Products Offered
12.8.5 Actavis Generics Recent Development
12.9 Dr. Reddy's Laboratories
12.9.1 Dr. Reddy's Laboratories Corporation Information
12.9.2 Dr. Reddy's Laboratories Description and Business Overview
12.9.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Dr. Reddy's Laboratories Imatinib Drugs Products Offered
12.9.5 Dr. Reddy's Laboratories Recent Development
12.10 Teva Pharmaceutical Industries Ltd.
12.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
12.10.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
12.10.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Products Offered
12.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.11 Apotex Inc.
12.11.1 Apotex Inc. Corporation Information
12.11.2 Apotex Inc. Description and Business Overview
12.11.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Apotex Inc. Imatinib Drugs Products Offered
12.11.5 Apotex Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Imatinib Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Imatinib Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Imatinib Drugs Market Segments
Table 2. Ranking of Global Top Imatinib Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Imatinib Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Capsules
Table 5. Major Manufacturers of Tablets
Table 6. Global Imatinib Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Imatinib Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Imatinib Drugs Sales by Regions 2015-2020 (K MT)
Table 9. Global Imatinib Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Imatinib Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Imatinib Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 12. Global Imatinib Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Imatinib Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Imatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Imatinib Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imatinib Drugs as of 2019)
Table 16. Imatinib Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Imatinib Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Imatinib Drugs Price (2015-2020) (USD/MT)
Table 19. Imatinib Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Imatinib Drugs Product Type
Table 21. Date of International Manufacturers Enter into Imatinib Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Imatinib Drugs Sales by Type (2015-2020) (K MT)
Table 24. Global Imatinib Drugs Sales Share by Type (2015-2020)
Table 25. Global Imatinib Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Imatinib Drugs Revenue Share by Type (2015-2020)
Table 27. Imatinib Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Imatinib Drugs Sales Share by Type (2021-2026)
Table 29. Global Imatinib Drugs Sales by Application (2015-2020) (K MT)
Table 30. Global Imatinib Drugs Sales Share by Application (2015-2020)
Table 31. Global Imatinib Drugs Sales Share by Application (2021-2026)
Table 32. Global Imatinib Drugs Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Imatinib Drugs Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Imatinib Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States Imatinib Drugs Sales (K MT) of Key Companies (2015-2020)
Table 36. United States Imatinib Drugs Sales Share by Company (2015-2020)
Table 37. United States Imatinib Drugs Revenue (US$ Million) by Company (2015-2020)
Table 38. United States Imatinib Drugs Sales (K MT) by Type (2015-2020)
Table 39. United States Imatinib Drugs Sales Share by Type (2015-2020)
Table 40. United States Imatinib Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States Imatinib Drugs Price (K MT) by Type (2015-2020)
Table 42. United States Imatinib Drugs Sales (K MT) by Type (2021-2026)
Table 43. United States Imatinib Drugs Sales Share by Type (2021-2026)
Table 44. United States Imatinib Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States Imatinib Drugs Revenue Share by Type (2021-2026)
Table 46. United States Imatinib Drugs Price (K MT) by Type (2021-2026)
Table 47. United States Imatinib Drugs Sales (K MT) by Application (2015-2020)
Table 48. United States Imatinib Drugs Sales Share by Application (2015-2020)
Table 49. United States Imatinib Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States Imatinib Drugs Sales (K MT) by Application (2021-2026)
Table 51. United States Imatinib Drugs Sales Share by Application (2021-2026)
Table 52. United States Imatinib Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States Imatinib Drugs Revenue Share by Application (2021-2026)
Table 54. North America Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 55. North America Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 56. North America Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 58. Europe Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 59. Europe Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 60. Europe Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Imatinib Drugs Sales by Region (2015-2020) (K MT)
Table 63. Asia Pacific Imatinib Drugs Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Imatinib Drugs Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Imatinib Drugs Revenue Market Share by Region (2015-2020)
Table 66. Latin America Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 67. Latin America Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 71. Middle East and Africa Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 74. Apotex Inc. Corporation Information
Table 75. Apotex Inc. Description and Business Overview
Table 76. Apotex Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Apotex Inc. Imatinib Drugs Product
Table 78. Apotex Inc. Recent Development
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Business Overview
Table 81. Novartis Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Novartis Product
Table 83. Novartis Recent Development
Table 84. Sanofi S.A. Corporation Information
Table 85. Sanofi S.A. Description and Business Overview
Table 86. Sanofi S.A. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Sanofi S.A. Product
Table 88. Sanofi S.A. Recent Development
Table 89. Cipla Inc. Corporation Information
Table 90. Cipla Inc. Description and Business Overview
Table 91. Cipla Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Cipla Inc. Product
Table 93. Cipla Inc. Recent Development
Table 94. Mylan Pharms Inc. Corporation Information
Table 95. Mylan Pharms Inc. Description and Business Overview
Table 96. Mylan Pharms Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Mylan Pharms Inc. Product
Table 98. Mylan Pharms Inc. Recent Development
Table 99. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 100. Glenmark Pharmaceuticals Ltd. Description and Business Overview
Table 101. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Glenmark Pharmaceuticals Ltd. Product
Table 103. Glenmark Pharmaceuticals Ltd. Recent Development
Table 104. Sun Pharmaceuticals Corporation Information
Table 105. Sun Pharmaceuticals Description and Business Overview
Table 106. Sun Pharmaceuticals Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Sun Pharmaceuticals Product
Table 108. Sun Pharmaceuticals Recent Development
Table 109. Actavis Generics Corporation Information
Table 110. Actavis Generics Description and Business Overview
Table 111. Actavis Generics Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Actavis Generics Product
Table 113. Actavis Generics Recent Development
Table 114. Dr. Reddy's Laboratories Corporation Information
Table 115. Dr. Reddy's Laboratories Description and Business Overview
Table 116. Dr. Reddy's Laboratories Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Dr. Reddy's Laboratories Product
Table 118. Dr. Reddy's Laboratories Recent Development
Table 119. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 120. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 121. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Teva Pharmaceutical Industries Ltd. Product
Table 123. Teva Pharmaceutical Industries Ltd. Recent Development
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Imatinib Drugs Players
Table 128. Imatinib Drugs Customers List
Table 129. Imatinib Drugs Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Imatinib Drugs Product Picture
Figure 2. Global Imatinib Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Capsules Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Imatinib Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Drug Stores
Figure 8. Other
Figure 9. Imatinib Drugs Report Years Considered
Figure 10. Global Imatinib Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Imatinib Drugs Sales 2015-2026 (K MT)
Figure 12. Global Imatinib Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Imatinib Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Imatinib Drugs Sales Market Share by Region in 2019
Figure 15. Global Imatinib Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Imatinib Drugs Revenue Market Share by Region in 2019
Figure 17. Global Imatinib Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Imatinib Drugs Revenue in 2019
Figure 19. Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Imatinib Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Imatinib Drugs Sales Market Share by Type in 2019
Figure 22. Global Imatinib Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Imatinib Drugs Revenue Market Share by Type in 2019
Figure 24. Global Imatinib Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Imatinib Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Imatinib Drugs Sales Market Share by Application in 2019
Figure 27. Global Imatinib Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Imatinib Drugs Revenue Market Share by Application in 2019
Figure 29. United States Imatinib Drugs Sales Growth Rate 2015-2026 (K MT)
Figure 30. United States Imatinib Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. United States Imatinib Drugs Market Share in Global Market 2015-2026
Figure 32. United States 5 and 10 Largest Imatinib Drugs Players Market Share by Revenue in Imatinib Drugs in 2019
Figure 33. United States Imatinib Drugs Revenue Share by Type (2015-2020)
Figure 34. United States Imatinib Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 35. United States Imatinib Drugs Revenue Share by Application (2015-2020)
Figure 36. United States Imatinib Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 38. North America Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Imatinib Drugs Sales Market Share by Country in 2019
Figure 40. North America Imatinib Drugs Revenue Market Share by Country in 2019
Figure 41. U.S. Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 42. U.S. Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. Canada Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Imatinib Drugs Sales Market Share by Country in 2019
Figure 48. Europe Imatinib Drugs Revenue Market Share by Country in 2019
Figure 49. Germany Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. France Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Imatinib Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Imatinib Drugs Revenue Market Share by Region in 2019
Figure 63. China Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Imatinib Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Imatinib Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Imatinib Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Imatinib Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Imatinib Drugs Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs